Literature DB >> 3059767

Identification and characterization of a non-interferon antileishmanial macrophage activating factor (antileishmanial MAF).

A Van Niel1, S E Zacks, J R David, H G Remold, W Y Weiser.   

Abstract

A non-interferon lymphokine elaborated from PHA and Con A-stimulated human T-cell hybridoma, T-CEMA, has been found to activate monocyte-derived macrophages for the intracellular killing of L. donovani (antileishmanial MAF). This T-cell hybridoma derived antileishmanial MAF which has an apparent mw of 65,000 and pI of 5.3-5.6, contains neither antiviral activity nor colony stimulating activity. Furthermore, antileishmanial MAF is not neutralized by anti-MIF, anti-IFN-gamma or anti-GM-CSF antibodies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3059767     DOI: 10.1007/978-1-4757-5421-6_23

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  1 in total

1.  An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate.

Authors:  Jamie Zagozewski; Ghazaleh M Shahriary; Ludivine Coudière Morrison; Olivier Saulnier; Margaret Stromecki; Agnes Fresnoza; Gareth Palidwor; Christopher J Porter; Antoine Forget; Olivier Ayrault; Cynthia Hawkins; Jennifer A Chan; Maria C Vladoiu; Lakshmikirupa Sundaresan; Janilyn Arsenio; Michael D Taylor; Vijay Ramaswamy; Tamra E Werbowetski-Ogilvie
Journal:  Nat Commun       Date:  2020-07-20       Impact factor: 14.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.